Press release
Bioabsorbable Stents Market Research Report by Leading Key Players –Zorion Medical, Tepha, S3V Vascular Technologies, REVA Medical, Kyoto Medical Planning, ICON Interventional Systems, Biotronik, Amaranth Medical, and Abbott Vascular - P&S Intelligence
The increasing incidences of cardiovascular diseases (CVDs) and increasing number of obese people worldwide are some of the major growth drivers for the global bioabsorbable stents market. CVDs are characterized by disorders of the heart and blood vessels. The major disorders include cerebrovascular disease, coronary heart disease, and rheumatic heart disease. People at risk of CVDs are affected with increased blood pressure, as well as obesity. According to the World Health Organization (WHO), 17.5 million people die from CVDs every year around the world.Access report overview: https://www.psmarketresearch.com/market-analysis/bioabsorbable-stents-market
Stent is a device, which is inserted into the blood vessels to expand the vessel and prevent blockage. Bioabsorbable stents are manufactured by materials, which are absorbed in the human body. Most bioabsorbable stents are made with polylactic acid, a biodegradable material which is used in manufacturing of medical implants. Bioabsorbable stents have several advantages, such as it eliminates causes of potential inflammation, which can lead to restenosis and late-stent thrombosis. Moreover, the bioabsorbable stents are viable alternatives for permanent drug-eluting and bare metal stent implants.
Download Free Sample of This Research Report : https://www.psmarketresearch.com/market-analysis/bioabsorbable-stents-market/report-sample
Geographically, Europe leads the global bioabsorbable stents market, due to increasing awareness about therapeutic applications of stent technology in the treatment of CVDs. In addition, the huge investment by key players for the development of biodegradable stents and rapid product approval are propelling the growth of the bioabsorbable stents market in the region. The Asia-Pacific bioabsorbable stents market is growing with a significant rate, owing to increasing aging population and increasing prevalence of CVDs.
In Europe, Germany, the U.K., France, and Italy are some of the major countries, holding significant share of the bioabsorbable stents market of the region. In North America, the U.S, followed by Canada, is the largest market for bioabsorbable stents. In Asia-Pacific, India, Japan, and China are the major markets for bioabsorbable stents. The Asia-Pacific bioabsorbable stents market is expected to witness fastest growth, attributed to the increasing healthcare expenditure and presence of large pool of patients.
Make enquiry before buying the report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=bioabsorbable-stents-market
Some of the major players operating in global bioabsorbable stents market include, Zorion Medical, Tepha, S3V Vascular Technologies, REVA Medical, Medlogics Device Corporation, Kyoto Medical Planning, ICON Interventional Systems, Elixir Medical Corporation, Biotronik, Arterial Remodelling Technologies Arterius, Amaranth Medical, and Abbott Vascular.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bioabsorbable Stents Market Research Report by Leading Key Players –Zorion Medical, Tepha, S3V Vascular Technologies, REVA Medical, Kyoto Medical Planning, ICON Interventional Systems, Biotronik, Amaranth Medical, and Abbott Vascular - P&S Intelligence here
News-ID: 1578623 • Views: …
More Releases for CVDs
Global Cardiovascular Diagnostic & Monitoring Devices Market to Reach Over USD 2 …
The global cardiovascular diagnostic & monitoring devices market, valued at USD 14.2 billion in 2021, is projected to nearly double to over USD 29.0 billion by the end of 2031, expanding at a robust CAGR of 7.5% over the forecast period (2022-2031). Fueled by the surging burden of chronic cardiovascular diseases (CVDs), demand for early diagnosis, and rapid technological advancements including AI‐enabled monitors and minimally invasive implants the market presents…
Contrast Enhanced Ultrasound Market by Product (Equipment, Nanoparticle & Molecu …
"The contrast-enhanced ultrasound market is projected to grow at a CAGR of 6.1% during the forecast period (2023-2028)."
The global contrast-enhanced ultrasound market is projected to reach USD 2.1 billion by 2028 from USD 1.6 billion in 2023, at a CAGR of 6.1% from 2023 to 2028. Factors such as rising geriatric population and increasing use of contrast agents are responsible for the increasing growth of this market. Increasing research and…
RAS-acting Agents Market to Reach US$ 13.4 Billion by 2031 Due to Increase in pr …
The global 𝗥𝗔𝗦-𝗮𝗰𝘁𝗶𝗻𝗴 𝗔𝗴𝗲𝗻𝘁𝘀 market is estimated to attain a valuation of US$ 13.4 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 4.2% during the forecast period, 2023-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of…
Ventricular Assist Devices Market to Reach US$ 2.80 Billion by 2027, Fueled by R …
According to the latest report by IMARC Group, titled "Ventricular Assist Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global ventricular assist devices market reached a value of US$ 1.56 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.80 Billion by 2027, exhibiting at a CAGR of 10.09% during 2022-2027. A ventricular assist device (VAD), also called a mechanical circulatory…
Rising Prevalence of CVDs Leads to Increasing Demand for Cardiac Biomarkers
In 2021, the cardiac biomarkers industry contributes $8,459.6 million, and it is projected to rise at a rate of 10.5%, to capture $20,718.8 million revenue in 2030. It is led by the rising prevalence of acute coronary syndrome, increasing point-of-care testing kit demand, and technological advancements in the industry.
Moreover, the surging investments in biomarker research, increasing CVDs incidences, and rising geriatric population are projected to boost the industry growth.…
Global rise in the incidence and prevalence rate of cardiovascular diseases (CVD …
Global Cardiovascular Information Systems (Cvis) Market is projected to grow at a considerable growth rate owing to increasing prevalence of CVDs across the globe. According to WHO, in 2018, CVDs accounts for 17.7 million mortality per year, which means 31% mortalities across the globe. The CVIS systems support in the assessment of chronic conditions such as CHD (coronary heart disease), stroke, and other heart related disease. CVIS systems allow assembling…
